Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Neighbourly Pharmacy Inc T.NBLY

Healthcare
Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or... see more

Bullboard (TSX:NBLY)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Post by Kanatainvestoron Oct 19, 2023 9:59am

The trading action affirms the need for NBLY to go private

This trickling decline on low volume, despite a signed letter of intent to go private, is in itself a confirmation as to why Neighbourly needs to go private. PCP has a much better chance of ...more  
143
Discussion
Post by gunner1324on Oct 18, 2023 3:43pm

SP

So is the SP getting brought down to give the minority shareholders a chance to avg down and in turn get their votes ? I sold out the day after announcement and got back in and will continue .
79
Comment by Kanatainvestoron Oct 17, 2023 12:20pm

RE:National Bank/Desjardin/Cormark/BMO take deal comments

Sorry post title should have been "National Bank/Desjardin/Cormark/BMO take private deal comments"
62
Discussion
Post by Kanatainvestoron Oct 17, 2023 12:19pm

National Bank/Desjardin/Cormark/BMO take deal comments

National Bank - Oct 3rd : “While the takeout price is a bitter pill for investors who participated in subsequent financing rounds (see Figure 1) or supported the stock in the $30s, we believe the ...more  
166
Discussion
Post by Kanatainvestoron Oct 17, 2023 9:55am

Canada inflation slows to 3.8%, backing rate pause

Canada’s rate of inflation unexpectedly slowed, with core measures showing some improvements, leaving room for the central bank to keep interest rates unchanged next week. The consumer price index ...more  
72
Post by Kanatainvestoron Oct 16, 2023 4:20pm

Interesting comments from Scotia (pre-deal)

This was published by Scotia on Sept 25th (Scotia has a $24 price target). Neighbourly Pharmacy Inc. We hosted a fireside chat with Neighbourly Pharmacy’s CEO Skip Bourdo and CFO Billy Wong. Our ...more  
140
Post by Kanatainvestoron Oct 11, 2023 7:55pm

Veritas comments on the deal

The company disclosed in Tuesday’s news release that it had hired TD Securities Inc. to give a fair market value for the company, which TD pegged between $20.50 to $25.50. Veritas analysts Kathleen ...more  
199
Comment by incomedreamer11on Oct 11, 2023 3:52pm

RE:RE:RE:30%+ Annual reutrn from current levels

I got from my stink bid small amount shares ( 13.05 CAD) and sold on announcement ( 19 $) Now, if it will be around 15-17 CAD will buy againg using margin account ,if not - no problem
87
Discussion
Comment by Kanatainvestoron Oct 11, 2023 3:46pm

RE:RE:30%+ Annual reutrn from current levels

Comparing this to the Cineplex deal at the outset of Covid is quite a stretch. This is a totally different setup. Having said that, of course there is always a chance of a black swan, but this risk is ...more  
109
Discussion
Comment by incomedreamer11on Oct 11, 2023 3:33pm

RE:30%+ Annual reutrn from current levels

I remember Cineplex done deal. Global unstability ,black swan event etc., lots can be happened. Better get money for somebody now and deploy somewhere else
77
Discussion
Post by Kanatainvestoron Oct 11, 2023 2:31pm

30%+ Annual reutrn from current levels

assuming the deal closes in 90 days. The amazing thing people were paying as much for the stock in August with no deal on the table. The stock pricing inefficiency of small volume stocks is astounding ...more  
135
Discussion
Post by Possibleidiot01on Oct 07, 2023 5:27pm

cantechletter.com

By Nick Waddell Published on October 3, 2023 Last Updated on October 3, 2023 Filed under:   All posts Stock:   nbly Neighbourly Pharmacy stock soars on go ...more  
147
Post by Kanatainvestoron Oct 04, 2023 6:08pm

Fully committed debt and equity financing

According to Marketscreener, PCP already secured fully committed debt and equity financing (I have not seen this mentioend anywhere else): PCP GP, L.P. entered into a letter of intent to acquire ...more  
156
Post by Kanatainvestoron Oct 04, 2023 2:37pm

This Deal Will Close

I wouldn’t expect financing to be much of an issue for this deal. The press release indicated that the deal will be financed with equity and debt. The equity in this instance is likely coming from pre ...more  
133
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities